CLOPINASE AP 150

Clopivas AP 150 Tablet is a formulation that combines two antiplatelet agents, functioning as a blood thinner to help mitigate the risk of harmful blood clot formation within blood vessels. It is specifically indicated for the prevention of heart attacks and strokes in individuals diagnosed with heart conditions. Additionally, the tablet is utilized in the management of acute coronary syndrome (ACS), a serious condition characterized by a sudden reduction of blood flow to the heart. It is important to take Clopivas AP 150 Tablet consistently with meals at the same time each day to enhance adherence to the treatment regimen. Patients should follow the prescribed schedule from their healthcare provider regarding the dosage and duration of therapy, as these factors may vary based on the underlying condition being treated. It is crucial not to discontinue the medication prematurely, even if symptoms improve. To maximize the effectiveness of this treatment, lifestyle modifications such as following a low-fat diet, engaging in regular physical activity, and avoiding smoking are recommended. Users should be aware that this medication may elevate the risk of bleeding, requiring caution during activities involving sharp objects or while grooming. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.